,使granzyme B

Trevor S Anderson1, Amanda L McCormick1, Savanna L Smith1

  • 1Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, 1718 Pine Street, Office 1306, Abilene, TX, 79601, USA.

BMC biology
|March 15, 2024
PubMed
概括

这项研究引入了一种新的基于酶B的抗体融合蛋白 (AFP),用于对抗体药物合物 (ADC) 候选人的初步查. 这种方法通过在体外可靠地评估关键抗体参数来简化ADC的开发.